Cost Saving Neditol 2018-05-10T13:02:02+00:00

NeditolLogonew600

HEALTHCARE PROFESSIONALS

Cost Saving

A £16.9m annual saving for the NHS1

Saving an average CCG £80,100pa1*

Save 50% of the cost of category C tolterodine 4mg prescriptions by prescribing Neditol® XL.2**

Tolterodine XL currently costs the NHS £33.8 million per annum.1
By prescribing Neditol XL by brand, the average savings for a CCG will be more than £80,100 per year providing the NHS with a total annual prescribing cost saving of over £16.9m per year.1*

Neditol XL Cost Calculator

To find out how much you can save by prescribing Neditol XL, please follow the instructions on the Neditol XL calculator:

Neditol Cost Calculator

…….

NeditolLogonew600

Neditol XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • 50% saving on the Category C Drug Tariff price for 4mg XL;2**
  • Additional 2mg XL strength (available for the first time on the UK market);
  • High level of stockholdings;
  • Price guaranteed until 2019;***
  • Available from all mainline wholesalers;
  • Bioequivalent to the originator.3

letter Supply Guarantee Letter      Letter1 Price Guarantee Letter

ProductCategory C UK Drug Tariff PriceNeditol XL
Tolterodine prolonged-release capsule 4mg x 28£25.78£12.89
Tolterodine prolonged-release capsule 2mg x 28Not Available£11.60
References:  *Based on the data in reference 1 for 211 CCGs switching their tolterodine prolonged-release prescriptions to Neditol XL. **Based on 50% saving on the cost of Category C tolterodine prolonged-release tablets in the UK Drug Tariff. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2019 PPRS review, regardless of competitor activity.
References: 1) IMS Health BPI Data September 2013 – August 2014. 2) February 2017 UK Drug Tariff. 3) Data on file. 1010067149 v 1.0 June 2016.

For further information please call: 01730 231148, email: info@aspirepharma.co.uk or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Neditol XL, please see the abbreviated prescribing information.
Revision reference – Neditol XL_16__27/02/2017